NTRA Q2 2020 Earnings — Natera, Inc. Revenue & Financial Results | Market Cap Arena

NTRANatera, Inc.

$28B

Q2 2020 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$86M+16.3% YoY

Gross Profit

$40M45.7% margin

Operating Income

-$52M-59.7% margin

Net Income

-$60M-69.0% margin

EPS (Diluted)

$-0.75

QoQ Revenue Growth

-8.0%

Cash Flow

Operating Cash Flow

-$41M

Free Cash Flow

-$43M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$723M

Total Liabilities

$419M

Stockholders' Equity

$304M

Cash & Equivalents

$77M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$86M	$74M	+16.3%
Gross Profit	$40M	$31M	+29.5%
Operating Income	-$52M	-$29M	-80.4%
Net Income	-$60M	-$32M	-84.0%

Revenue Segments

Product

$80M93%

Licensing And Other

$6M7%

Geographic Segments

U

$81M93%

E M E A

$4M4%

Other Geographic Areas

$1M2%

Americas Excluding Us

$721,0001%